JP2010505848A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505848A5
JP2010505848A5 JP2009531464A JP2009531464A JP2010505848A5 JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5 JP 2009531464 A JP2009531464 A JP 2009531464A JP 2009531464 A JP2009531464 A JP 2009531464A JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5
Authority
JP
Japan
Prior art keywords
mrs
intraocular pressure
eye
administering
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009531464A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010505848A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/021409 external-priority patent/WO2008045330A2/en
Publication of JP2010505848A publication Critical patent/JP2010505848A/ja
Publication of JP2010505848A5 publication Critical patent/JP2010505848A5/ja
Pending legal-status Critical Current

Links

Images

JP2009531464A 2006-10-06 2007-10-05 眼内圧を低下させるための種交差性a3アデノシン受容体アンタゴニストの効果的送達 Pending JP2010505848A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85017506P 2006-10-06 2006-10-06
PCT/US2007/021409 WO2008045330A2 (en) 2006-10-06 2007-10-05 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure

Publications (2)

Publication Number Publication Date
JP2010505848A JP2010505848A (ja) 2010-02-25
JP2010505848A5 true JP2010505848A5 (cg-RX-API-DMAC7.html) 2010-11-25

Family

ID=39283379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009531464A Pending JP2010505848A (ja) 2006-10-06 2007-10-05 眼内圧を低下させるための種交差性a3アデノシン受容体アンタゴニストの効果的送達

Country Status (8)

Country Link
US (1) US20090258836A1 (cg-RX-API-DMAC7.html)
EP (1) EP2076267A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010505848A (cg-RX-API-DMAC7.html)
AU (1) AU2007307157A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0715318A2 (cg-RX-API-DMAC7.html)
CA (1) CA2665616A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009003750A (cg-RX-API-DMAC7.html)
WO (1) WO2008045330A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013516495A (ja) 2010-01-11 2013-05-13 イノテック ファーマシューティカルズ コーポレイション 眼圧を低下させる組合せ、キット、および方法
JP2013523739A (ja) * 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション N6−シクロペンチルアデノシン(cpa)、cpa誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法
SMT201700377T1 (it) 2012-01-26 2017-09-07 Inotek Pharmaceuticals Corp Polimorfi anidri di (2r,3s,4r,5r)-5-(6-(ciclopentilammino)-9h-purin-9-il)-3,4- diidrossitetraidrofuran-2-il)}metil nitrato e processi di sua preparazione
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
ES2578363B1 (es) 2015-01-22 2017-01-31 Palobiofarma, S.L. Moduladores de los receptores A3 de adenosina
US10196396B2 (en) 2016-01-14 2019-02-05 Handok Inc. Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof
ES2676535B1 (es) 2017-01-20 2019-04-29 Palobiofarma Sl Moduladores de los receptores a3 de adenosina
KR101805400B1 (ko) * 2017-03-21 2017-12-07 퓨쳐메디신 주식회사 아데노신 유도체를 포함하는 녹내장 예방 및 치료용 약학적 조성물
CN109666053A (zh) * 2017-10-16 2019-04-23 张家口华健致远生物科技有限公司 一种a3腺苷受体激动剂及其用途
KR102007640B1 (ko) * 2017-11-29 2019-08-07 퓨쳐메디신 주식회사 아데노신 유도체를 포함하는 망막 질환 또는 시신경 질환 예방 및 치료용 약학적 조성물
US11395597B2 (en) * 2018-06-26 2022-07-26 General Electric Company System and method for evaluating blood flow in a vessel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4431638B2 (ja) * 1996-01-29 2010-03-17 アメリカ合衆国 ジヒドロピリジン―、ピリジン―、ベンゾピラン―オン―およびトリアゾロキナゾリン誘導体、それらの製造およびそれらのアデノシン受容体アンタゴニストとしての用途
EP1096975B1 (en) * 1998-07-16 2005-03-16 The Trustees Of The University Of Pennsylvania Use of a3 adenosine receptor antagonists in the manufacture of a medicament for reducing intraocular pressure
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Similar Documents

Publication Publication Date Title
US12006328B2 (en) Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
RU2470635C2 (ru) Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза
WO2008045330A3 (en) Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure
JP6466504B2 (ja) 長時間の眼圧低下効果を有するアルファ−2アドレナリンアゴニスト
PT1511481E (pt) Utilização oftalmológica de roflumilast para o tratamento de doenças do olho
WO2017106306A1 (en) Methods of treating hyperalgesia
KR20070005911A (ko) 개선된 비-진정성 알파-2 효능제의 신규 동정 방법
JP2009504748A5 (cg-RX-API-DMAC7.html)
AU2023201678B2 (en) Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
JP2013500977A5 (cg-RX-API-DMAC7.html)
JP7858508B2 (ja) 近視の治療、近視の予防および/または近視の進行抑制のための医薬
CN1143321A (zh) 用5-ht2拮抗剂治疗观念与行为强迫症的方法
JP2018538354A (ja) Cftr制御因子及びこの使用方法
TR201809003T4 (tr) Motor bozukluklar için terapötik madde.
JP2010520174A5 (cg-RX-API-DMAC7.html)
CN102822188A (zh) 腺苷化合物及其用途
KR20240134157A (ko) 파킨슨 치료제의 개선된 코 투여
JP4308255B2 (ja) ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
JP6832336B2 (ja) アルコール乱用の治療におけるγ−ヒドロキシ酪酸の選択されたアミドおよびその使用
US20250353861A1 (en) Derivative of artemisinin and preparation method and use thereof
JP2009500398A5 (cg-RX-API-DMAC7.html)
JP2009500397A5 (cg-RX-API-DMAC7.html)
KR101891078B1 (ko) 황반변성 예방 또는 치료용 약학 조성물
WO2008086341A1 (en) Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
DE60318033T2 (de) Biguanid-derivate und deren verwendung als antidiabetika